Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more ... The study findings could influence ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight ... Now, he’s a Mets’ batting practice pitcher. NewsdayTV’s Carissa Kellman reports. Credit: Newsday/Kendall ...

Boxes for the medications Wegovy and Zepbound are arranged for a photograph in California on Thursday, May 8, 2025. (AP Photo/JoNel Aleccia) (Jonel Aleccia) People taking Eli Lilly's obesity drug ...